| |
| |
|
| Insider
Information: |
Levitt Daniel J |
| Relationship: |
Director |
| City: |
Berkeley |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
177,702 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$198,904 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
177,702 |
|
|
| Total
Value |
$198,904 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Dynavax Technologies Corp |
DVAX |
Officer |
2004-02-11 |
16,666 |
|
0 |
Premium* |
|
|
Ladrx |
LADX |
EVP and Chief Medical ... |
2014-01-01 |
161,036 |
2012-02-22 |
0 |
Premium* |
|
|
Neurogene |
NGNE |
Director |
2018-05-14 |
0 |
2018-05-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NGNE |
Neurogene |
Director |
– • – |
2018-05-14 |
4 |
S |
$12.67 |
$49,489 |
D/D |
(3,906) |
0 |
0 |
- |
|
| NGNE |
Neurogene |
Director |
– • – |
2018-05-14 |
4 |
OE |
$10.56 |
$41,247 |
D/D |
3,906 |
3,906 |
0 |
- |
|
| LADX |
Ladrx |
EVP and Chief Medical Officer |
• – – |
2014-01-01 |
4/A |
A |
$0.00 |
$0 |
D/D |
100,000 |
161,036 |
0 |
- |
|
| LADX |
Ladrx |
EVP and Chief Medical Officer |
• – – |
2014-01-01 |
4/A |
A |
$0.00 |
$0 |
D/D |
100,000 |
157,983 |
0 |
- |
|
| LADX |
Ladrx |
EVP and Chief Medical Officer |
• – – |
2014-01-01 |
4/A |
A |
$0.00 |
$0 |
D/D |
100,000 |
157,706 |
0 |
- |
|
| LADX |
Ladrx |
EVP and Chief Medical Officer |
• – – |
2014-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
214,286 |
0 |
- |
|
| LADX |
Ladrx |
EVP & Chief Medical Officer |
• – – |
2012-12-31 |
4/A |
A |
$0.00 |
$0 |
D/D |
100,000 |
114,286 |
0 |
- |
|
| LADX |
Ladrx |
Chief Medical Officer |
• – – |
2012-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
200,000 |
0 |
- |
|
| LADX |
Ladrx |
Chief Medical Officer |
• – – |
2012-02-22 |
4 |
B |
$0.29 |
$28,750 |
D/D |
100,000 |
100,000 |
2.74 |
- |
|
| DVAX |
Dynavax Technologies Corp |
VP & Chief Medical OfficerOffi |
• – – |
2004-02-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
16,666 |
|
- |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
